Open Access
Issue
Published:
02 November 2018
Resumption of Meiotic Maturation of Oocytes, Pre- and Post-Implantational Embryonic Mortality under Conditions of Experimental Glomerulonephritis and Treatment of Silver Nanoparticles
Download citation
346
Views
10
Downloads
0
Crossref
N/A
WoS
0
Scopus
N/A
CSCD
The aim of the current study was to estimate the resumption of meiotic maturation of oocytes, pre- and post-implantation mortality of embryos under conditions of experimental glomerulonephritis and intravenous treatment of silver nanoparticles in mice. Experimental glomerulonephritis in mice was achieved by immunization of white laboratory mice of the first generation with a kidney antigen suspension derived from a parent. The treatment was carried out in the following way: Kidney antigen suspension - intraperitoneal three times 1 time per day; the procedure was repeated in 3 weeks, one time intraperitoneally with the same dose (10 mkL of suspension per 10 grams of body weight of the animal). Silver nanoparticles (AgNPs, 30 nm) - intravenous treatment three times: 1 time per day for 1 h before immunization of animals with suspension of kidney antigen; as well as in 3 weeks once with the same dose (2 mg/kg). Thus, the number of oocytes that resumed meiosis in vitro from animals under experimental glomerulonephritis decreased as compared to the numbers in control animals; no inhibition of meiotic resumption of oocytes of animals was established under conditions of AgNPs treatment; the AgNPs treatment under conditions of experimental glomerulonephritis increased the number of oocytes that resumed meiosis in vitro compared with such values in the control and under conditions of experimental glomerulonephritis. The value of post-implantation embryonic mortality increased under conditions of experimental glomerulonephritis; no infertility of implantation in females of mice under conditions of AgNPs treatment; the AgNPs treatment under conditions of experimental glomerulonephritis decreased post-implantation mortality of embryos.
menu
Resumption of Meiotic Maturation of Oocytes, Pre- and Post-Implantational Embryonic Mortality under Conditions of Experimental Glomerulonephritis and Treatment of Silver Nanoparticles
Abstract
The aim of the current study was to estimate the resumption of meiotic maturation of oocytes, pre- and post-implantation mortality of embryos under conditions of experimental glomerulonephritis and intravenous treatment of silver nanoparticles in mice. Experimental glomerulonephritis in mice was achieved by immunization of white laboratory mice of the first generation with a kidney antigen suspension derived from a parent. The treatment was carried out in the following way: Kidney antigen suspension - intraperitoneal three times 1 time per day; the procedure was repeated in 3 weeks, one time intraperitoneally with the same dose (10 mkL of suspension per 10 grams of body weight of the animal). Silver nanoparticles (AgNPs, 30 nm) - intravenous treatment three times: 1 time per day for 1 h before immunization of animals with suspension of kidney antigen; as well as in 3 weeks once with the same dose (2 mg/kg). Thus, the number of oocytes that resumed meiosis in vitro from animals under experimental glomerulonephritis decreased as compared to the numbers in control animals; no inhibition of meiotic resumption of oocytes of animals was established under conditions of AgNPs treatment; the AgNPs treatment under conditions of experimental glomerulonephritis increased the number of oocytes that resumed meiosis in vitro compared with such values in the control and under conditions of experimental glomerulonephritis. The value of post-implantation embryonic mortality increased under conditions of experimental glomerulonephritis; no infertility of implantation in females of mice under conditions of AgNPs treatment; the AgNPs treatment under conditions of experimental glomerulonephritis decreased post-implantation mortality of embryos.
References(27)
G. Braun, T. Friman, H. Pang, et al., Etchable plasmonic nanoparticle probes to image and quantify cellular internalization. Nat Mater, 2014, 13(9): 904-911.
G. Malik, A. Al-Harbi, S. Al-Mohaya, et al., Repeated pregnancies in patients with primary membranous glomerulonephritis. Nephron, 2002. 91(1): 21-24.
A. Al-Harbi, G. Malik, S. Al-Mohaya, et al., Anti-glomerular Basement Membrane Antibody Disease Presenting as Acute Renal Failure During Pregnancy. Saudi J Kidney Dis Transpl, 2003, 14(4): 516-521.
M. Segelmark, T. Hellmark, Autoimmune kidney diseases. Autoimmun Rev, 2010. 9(5): A366-371.
S. Reagan-Shaw, M. Nihal, and N. Ahmad, Dose translation from animal to human studies revisited. FASEB J, 2008, 22(3): 659-661.
K. Park, E. Park, I. Chun, et al., Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res, 2011, 34: 153-158.
Y. Xue, S. Zhang, Y. Huang, et al., Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J Appl Toxicol, 2012, 32: 890-899.
W. De Jong, L. Van Der Ven, A. Sleijffers, et al., Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials, 2013, 34: 8333-8343.
C. Rigo, L. Ferroni, I. Tocco, et al., Active silver nanoparticles for wound healing. Int J MolSci, 2013, 14(3): 4817-4840.
L. Wei, J. Lu, H. Xu, et al., Silver nanoparticles: Synthesis, properties, and therapeutic applications. Drug Discov Today, 2015, 20(5): 595-601.
M. van der Zande, R. Vandebriel, E. Van Doren, et al., Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano, 2012, 6(8): 7427-7442.
J. Kwon, A. Minai-Tehrani, S. Hwang, et al., Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res, 2012, 28(1): 25-31.
P. Li, T. Kuo, J. Chang, et al., Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett, 2010, 197(2): 82-87.
U. Taylor, W. Garrels, A. Barchanski, et al., Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development. Beilstein J Nanotechnol, 2014, 21(5): 677-688.
W. Yu, J. Son, J. Lee, et al., Effects of silver nanoparticles on pregnant dams and embryo-fetal development in rats. Nanotoxicology, 2014, 8(1): 85-91.
A. Lytvynenko, L. Rieznichenko, V. Sribna, et al., Functional status of reproductive system under treatment of silver nanoparticles in female mice. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2017, 6(5): 1713-1720.
H. Johnston, G. Hutchison, F. Christensen, et al., A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol, 2010, 40(4): 328-346.
D. Tiedemann, U. Taylor, C. Rehbock, et al., Reprotoxicity of gold, silver, and gold-silver alloy nanoparticles on mammalian gametes. Analyst, 2014, 139(5): 931-942.
U. Taylor, D. Tiedemann, C. Rehbock, et al., Influence of gold, silver and gold-silver alloy nanoparticles on germ cell function and embryo development. Beilstein J Nanotechnol, 2015, 5(6): 651-664.
T. Voznesenskaya, M. Stupchuk, N. Grushka, et al., The influence of the tretment of silver nanoparticles on the DNA of the nuclei of thymus cells, lymph nodes and the follicular environment of the oocyte under conditions of experimental systemic autoimmune disorder. Bulletin of Problems Biology and Medicine, 2018, 1(143): 327-331[in Ukrainian].
N. Durán, M. Durán, M. de Jesus, et al., Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. Nanomedicine, 2016, 12(3): 789-799.
Y. Hsin, C. Chen, S. Huang, et al., The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett, 2008, 179(3): 130-139.
G. Laban, L. Nies, R. Turco, et al., The effects of silver nanoparticles on fathead minnow (Pimephalespromelas) embryos. Ecotoxicology, 2010, 19(1): 185-195.
S. Chernousova, M. Epple, Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl, 2013, 52(6): 1636-1653.
J. Choi, S. Kim, J. Ahn, et al., Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol, 2010, 100(2): 151-159.
J. Maillard, P. Hartemann, Silver as an antimicrobial: facts and gaps in knowledge. Crit Rev Microbiol, 2013, 39(4): 373-383.
C. Recordati, M. De Maglie, S. Bianchessi, et al., Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol, 2016, 29(13): 12.
Publication history
Copyright
Acknowledgements
We wish to thank Ovcharenko Institute of Biocolloidal Chemistry, National Academy of Sciences (NAS) of Ukraine and Ms. Ludmila Rieznichenko, PhD for providing the samples of AgNPs for this research.
Rights and permissions
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
FEEDBACK 
TOP